Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.86/Share
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $2.30 +28.49%
EPS Growth %: +100.0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: +100.0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.95) reported last year. Revenue for the quarter came in at $715 thousand, versus $205 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- Impinj (PI) Tops Q1 EPS by 11c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
